The Endocrine Society and the European Society of Endocrinology (ESE) have reached an historic agreement to jointly develop Clinical Practice Guidelines providing evidence-based recommendations for clinical care and practice.
Endocrine Society President Gary D. Hammer, M.D., Ph.D., and European Society of Endocrinology President Andrea Giustina, M.D., signed the agreement during the 22nd European Congress of Endocrinology’s opening ceremony, held virtually on Saturday, Sept. 5.
Developing globally relevant guidelines will support the delivery of up-to-date care to patients worldwide. The joint Clinical Practice Guideline program also will recognize global differences in access to diagnostic tools and therapies.
“This historic collaboration between the Endocrine Society and the European Society of Endocrinology is an important step to provide a unified global voice and to increase the reach and relevance of Clinical Practice Guidelines,” Hammer said. “ESE shares our robust approach to researching and vetting guidelines, and our organizations are proud to serve as international leaders in this groundbreaking effort.”
Jointly developed guidelines will help ensure clinicians who treat endocrine conditions such as diabetes, obesity, osteoporosis, thyroid and adrenal conditions together with hormone-related cancers will have access to a consistent, timely set of patient care recommendations. The unified guidelines will help health care providers provide better patient care, improve health care outcomes, increase patient safety and control health care costs.
“We are very pleased to be working with our friends at the Endocrine Society to develop the Guidelines,” Giustina said. “This is perfectly aligned with the vision of my presidency, which is inclusion and putting the patient at the heart of everything we do. I feel sure this is the start of something great and an historical step towards the creation of a strong global endocrine community.”
This collaboration will kick off with the development of two inaugural guidelines: Diabetes in Pregnancy, led by the Endocrine Society, and Management of Corticosteroid Therapy, led by the European Society of Endocrinology.
For more information on our Clinical Practice Guidelines, visit https://www.endocrine.org/clinical-practice-guidelines and https://www.ese-hormones.org/publications/guidelines/.
# # #
About the Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.
About the European Society of Endocrinology
At the European Society of Endocrinology (ESE), we are working together to develop and share the best knowledge in endocrine science and medicine. ESE represents a community of over 20,000 European endocrinologists, enabling us to inform policy makers on health decisions at the highest level through engagement in advocacy efforts across Europe. It is by uniting and representing every part of the endocrine community that we are placed in the best possible position to improve life for the patient.
To find out more please visit www.ese-hormones.org. Follow us on Twitter @ESEndocrinology, Facebook @EuropeanSocietyofEndocrinology and LinkedIn: linkedin.com/company/european-society-of-endocrinology.
e-ECE 2020 was held online from the 5-9 September. See the scientific programme for more information.
